Anti-infection Agents

Similar documents
Anti-infection Agents

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

2015 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

EUCAST recommended strains for internal quality control

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Antibiotic Usage Guidelines in Hospital

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antimicrobial Susceptibility Testing: Advanced Course

Antibiotic Updates: Part II

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

* gender factor (male=1, female=0.85)

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

** the doctor start the lecture with revising some information from the last one:

European Committee on Antimicrobial Susceptibility Testing

Rational management of community acquired infections

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Antimicrobial Pharmacodynamics

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Chapter 46. Learning Objectives (cont d)

Antimicrobial Susceptibility Patterns

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Antibiotics 1. Lecture 8

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

General Approach to Infectious Diseases

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Should we test Clostridium difficile for antimicrobial resistance? by author

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Approach to pediatric Antibiotics

Antimicrobial Susceptibility Testing: The Basics

number Done by Corrected by Doctor

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Other Beta - lactam Antibiotics

Antimicrobial susceptibility

Intrinsic, implied and default resistance

56 Clinical and Laboratory Standards Institute. All rights reserved.

January 2014 Vol. 34 No. 1

What s new in EUCAST methods?

EUCAST-and CLSI potency NEO-SENSITABS

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Scottish Medicines Consortium

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Concise Antibiogram Toolkit Background

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Management of Hospital-acquired Pneumonia

number Done by Corrected by Doctor

What s next in the antibiotic pipeline?

Suggested treatment. Inj Crystalline Penicillin 50,000U/Kg i.v. 4-6hrly (if child cannot swallow) 40mg/Kg/dose BID x 10days

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report

Appropriate antimicrobial therapy in HAP: What does this mean?

High Antibiotic Resistance Pattern Observed in Bacterial Isolates from a Tertiary Hospital in South East Nigeria

Antimicrobial Therapy

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Infectious Disease: Drug Resistance Pattern in New Mexico

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

CONTAGIOUS COMMENTS Department of Epidemiology

Measuring Antibiotic Use in NHSN

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

British Society for Antimicrobial Chemotherapy

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

DR. BASHIRU BOI KIKIMOTO

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report

3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

Antimicrobial Stewardship Program

CONTAGIOUS COMMENTS Department of Epidemiology

Provincial Drugs & Therapeutics Committee Memorandum Version 2

Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults

ICAAC. Key words: antibacterial agent development approval. linezolid β. chloramphenicol tetracycline colistin mupirocin teicoplanin

Rational use of antibiotics

Transcription:

Supecef Pow. for Inj. 0.5g 1 Supecef Pow. for Inj. 1g 1 Cefuroxime Pow. for Inj. 750mg 1 Tatumcef Pow. for Inj 0.5g 2 Tatumcef Pow. for Inj 1g 2 Tatumcef Pow. For Inj. 2g 2 Cefazolin Injection 1g 3 Pisutam (Lyo) Lyo for Inj. 2.25g 4 Pisutam (Lyo) Lyo for Inj. 4.5g 4 Pipe&Tazo CYH Pow. for Inj. 2.25g 4 Piperacillin CYH Pow. for Inj. 2g 5 Picillina Pow. for Inj. 4g 5 Ocillina Pow. for Inj. 0.5g 5 Oxacillin CYH Pow. for Inj. 1g 6 Amsulber CYH Pow. for Inj. 1.5g 6 AmoClav CYH Pow. for Inj. 0.6g 6 AmoClav CYH Pow. for Inj. 1.2g 7 Anbicyn F.C. Tab. 625mg 7 Amoxicillin Cap. 500mg 7 Aziciin F.C. Tablets 250mg F.C. Tablets 250mg 8 Colirocin F. C. Tab. 250mg 8 Vancomycin CYH Lyophilized 500 mg 9 Teicod Lyophilized 200 mg 9 Meropenem CYH Pow. for Inj. 0.5g 10 Culin Pow. for Inj. 0.5g 10 Moflodal Infusion Solut 400mg 11

Leflodal I.V. Solution 250mg 11 Leflodal I.V. Solution 500mg 11 Levofloxacin CYH F. C. Tab. 100mg 12 Leflodal F. C. Tab. 500 mg 12 Ciflodal F.C. Tab. 500 mg 12 Oflodal F.C. Tablets 100mg 13 Lisim Tab. 250mg 14 Femstat Supp. 0.1gm 14 Vibox F.C. Tablets 500mg 15 Envir F.C Tab. 0.5mg 15 Acylete Tab. 200mg 15 Acylete Tab. 400mg 16 Chlorhexidine CCPC Solution 200ml 17 Hand Sanitizer Gel 60ml 17 Hand Sanitizer Gel 500ml 17 Anti-A Solution Solution l0w/v% 18 Tigelin Lyo. for Inj. 50mg 19 Sulbactam Pow. for Inj. 500mg 19

Cephalosporins Supecef Supecef Cefuroxime K55 K58 K25 Pow. for Inj. Pow. for Inj. Pow. for Inj. 0.5g 1g 750mg Cefepime Cefepime Cefuroxime Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases 0.5GM*10V A049147277 1GM*10V A049147209 1 750MG*25V A030620289

Cephalosporins Tatumcef Tatumcef Tatumcef K28 K31 K32 Pow. for Inj Pow. for Inj Pow. For Inj. 0.5g 1g 2g Ceftazidime Ceftazidime Ceftazidime It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). 0.5GM*10V AC38949277 1GM*10V AC38949209 2 2GM*10V AC38949212

Cephalosporins Cefazolin K21 Injection 1g Cefazolin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. 1G*25V AC17712209 3

Penicillins Pisutam (Lyo) R57 Lyo for Inj. 2.25g Pisutam (Lyo) R59 Lyo for Inj. 4.5g Pipe&Tazo CYH Pow. for Inj. 2.25g PIP-TZ PIP-TZ PIP-TZ Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. 2.25GM*10V AC510362CX 4.5GM*10V AC51036220 4 2.25GM*10V AC567592CX

Penicillins Piperacillin CYH Picillina Ocillina K37 K54 Pow. for Inj. Pow. for Inj. Pow. for Inj. 2g 4g 0.5g Piperacillin Piperacillin Oxacillin Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. 2g*10V AC57844209 4GM*10V AC42828219 5 0.5GM*25V AC49000277

Penicillins Oxacillin CYH Amsulber CYH AmoClav CYH Pow. for Inj. Pow. for Inj. Pow. for Inj. 1g 1.5g 0.6g Oxacillin Ampicillin/Sulbactam Amox/Clav Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases induced by Streptococcus, Staphylococcus, E.coli, Klebsiela..(Please see IPC) Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. 1g*10V AC57753209 1.5GM*10V AC57762210 6 0.6g*10V AC57877280

Penicillins AmoClav CYH Anbicyn Amoxicillin E103 B32 Pow. for Inj. F.C. Tab. Cap. 1.2g 625mg 500mg Amox/Clav Amox/Clav Amoxicillin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcuspneumonia, Meningococcus, and other susceptible bacteria. 1.2g*10V AC57877297 120T/PTP AC42660100 7 1000C/BTL AC24132100/AC241321G0

Macrolides Aziciin F.C. Tablets 250mg Colirocin E116 F.C. Tablets F. C. Tab. 250mg 250mg Azithromycin Clarithromycin AECOPD/Acute bacterial sinusitis/cap/pharyngitis/tonsillitis/uncomplicated skin and skin structure infections/urethritis and cervicitis/genital ulcer disease Infectious diseases of the upper and lower airway caused by infectious bacteria. Can be used in conjunction with Omeprazole to treat duodenal ulcer associated with H. pylori. (Please see IPC) 6T/PTP 100T/BTL 28T/PTP; 500T/BTL AC44733100 8

Glycopeptide Vancomycin CYH Teicod R52 R53 Lyophilized Lyophilized 500 mg 200 mg Vancomycin Teicoplanin Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. 500 mg*10v AC57286277 200 mg*vial AC47895263 9

Carbapenems Meropenem CYH K48 Pow. for Inj. 0.5g Culin K57 Pow. for Inj. 0.5g Meropenem Imipenem/Cilastatin Infectious diseases induced by Meropenem-susceptible bacteria. Infectious diseases induced by Imipenem-susceptible gram negative and positive bacteria. 0.5GM*10V AC57285277 0.5GM*25V AC48189277 10

Quinolones Moflodal Leflodal Leflodal Q83 P43 P43 Infusion Solution I.V. Solution I.V. Solution 400mg 250mg 500mg Moxifloxacin Levofloxacin Levofloxacin Treatment of the following infections in adults (over 18 years old) caused by moxifloxacin-susceptible pathogenic bacteria: URTI, LRTI, SSSI, Complicated IAI, etc. Please see IPC for more information. Treatment of the following infections in adults caused by Levofloxacinsusceptible pathogenic bacteria: CAP, UTI, SSSI, etc. Please see IPC for more information. Treatment of the following infections in adults caused by Levofloxacinsusceptible pathogenic bacteria: CAP, UTI, SSSI, etc. Please see IPC for more information. 400mg/250ml*1V AC52120265 5mg/ml*50ml AC49651248 11 5mg/ml*100ml AC49651255

Quinolones Levofloxacin CYH Leflodal Ciflodal E147 E81 F. C. Tab. F. C. Tab. F.C. Tab. 100mg 500 mg 500 mg Levofloxacin Levofloxacin Ciprofloxacin Airway infectious diseases, otorhinolaryngological diseases, UTI, uterine infections, etc. Please see IPC for more information. Treatment infections in adults caused by Levofloxacin-susceptible pathogens. Please see IPC for more information. Infections disease. (Please see IPC) 1000T/BTL AC57300100 100T/PTP AC49696100 12 100T/BTL AC38528100

Quinolones Oflodal E89 F.C. Tablets 100mg Ofloxacin Infectious diseases (Please see IPC) 1000T/BTL AC39793100 13

Antifungal Drugs Lisim Femstat D63 J12 Tab. Supp. 250mg 0.1gm Terbinafine Butoconazole Nitrate Onychomyosis, tineacapitis, and severe, wide spread dermatomycosis not responding to local treatment. Vaginal infections caused by fungi. 14T/PTP;140T/PTP AC43575100 3 Supp./Box 14

Antiviral Drugs Vibox Envir Acylete E220 D57 F.C. Tablets F.C Tab. Tab. 500mg 0.5mg 200mg Valaciclovir Entecavir Acyclovir Herpes zoster; recurrent genital herpes prevention and treatment Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus.(please see IPC) 10T/PTP 42T/PTP AC57925100 30T/Box AA57322100 15 25T/BTL;100T/PTP AC40090100

Antiviral Drugs Acylete D54 Tab. 400mg Acyclovir Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus. (Please see IPC) 100T/BTL AC39315100 16

Antibacterial / disinfection Chlorhexidine CCPC Hand Sanitizer Hand Sanitizer F46 F42 F42 Solution Gel Gel 200ml 60ml 500ml Chlorhexidine 2%+IPA Ethyl Alcohol Ethyl Alcohol Germicidal, disinfection. Skin and hand cleaning, disinfection, germicidal. Skin and hand cleaning, disinfection, germicidal. 200ml 60ML/BTL 500ML/BTL 17

Antibacterial / disinfection Anti-A Solution F06 Solution l0w/v% Benzalkonium Cl. Germicidal, disinfection. 500ML / 5L 18

Others Tigelin Sulbactam R66 K59 Lyo. for Inj. Pow. for Inj. 50mg 500mg Tigecycline Sulbactam csssi, ciai, CAP A β-lactamase inhibitor, that have to combinate with Ampicillin. 10 vials/box AB57783248 500MG*10V AC54647277 19